Chemical and Pharmaceutical Bulletin p. 777 - 782 (1995)
Update date:2022-08-05
Topics:
Saito
Harada
Nishida
Inouye
Kubo
Treatment of (-)-saframycin A (1a) with selenium oxide in acetic acid afforded (-)-saframycin G (1g), and a catalytic reduction and regioselective oxidation sequence afforded the saframycin Mx type compound (3). We applied this methodology to the transformation of (±)-5-hydroxysaframycin B (11) to the hydroquinone (1e). Acetylation of 1e with acetic anhydride in pyridine gave the triacetate (13), which is identical with the triacetyl derivative of natural saframycin E.
View MoreContact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Neworld Chemical Co., Ltd Shanghai(expird)
Contact:+86-21-62202658
Address:11F, Blvd 2, No. 1969 PuXing Rd, Shanghai
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu，China
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
Doi:10.1016/j.tetasy.2014.04.001
(2014)Doi:10.1021/ol501301w
(2014)Doi:10.1021/acs.jmedchem.7b00592
(2017)Doi:10.1039/c4gc00273c
(2014)Doi:10.1016/j.bmc.2018.05.045
(2018)Doi:10.1016/j.bioorg.2021.104965
(2021)
